Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$283K Sell
3,841
-24
-0.6% -$1.81K 0.15% 57
2020
Q1
$283K Sell
3,865
-12
-0.3% -$943 0.19% 53
2019
Q4
$336K Buy
3,877
+53
+1% +$4.35K 0.17% 59
2019
Q3
$307K Sell
3,824
-131
-3% -$10.5K 0.16% 59
2019
Q2
$316K Buy
3,955
+149
+4% +$11.4K 0.18% 59
2019
Q1
$302K Buy
3,806
+93
+3% +$6.96K 0.19% 56
2018
Q4
$270K Buy
+3,713
New +$262K 0.2% 54

Other funds holding MRK

Rudd International's MRK Position: Q2 2020 in Review

Rudd International reduced its Merck (MRK) stake by 0.62% in Q2 2020, selling an estimated $1.81K and leaving 3,841 shares worth $283K. The position accounts for 0.15% of the portfolio, ranked #57.

Rudd International first reported a position in MRK in Q4 2018 and has held it in 7 quarters since. The position peaked at $336K in Q4 2019. 2,495 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • Rudd International held 3,841 shares of Merck worth $283K as of Q2 2020.
  • Rudd International sold 24 Merck shares in Q2 2020, an estimated $1.81K.
  • Merck made up 0.15% of Rudd International's portfolio in Q2 2020, its #57 holding.
  • Rudd International first reported a position in Merck in Q4 2018 and has held it in 7 quarters since.
  • Rudd International's Merck position peaked at $336K in Q4 2019.
  • 2,495 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on Rudd International's 13F filing for Q2 2020, filed 4 Aug 2020.